Sign up
Quantellect · Congress · Trade Detail
NYSE: NVSNovartis AG ADR
RepublicanHouse

Thomas MacArthur sold Novartis AG ADR (NYSE: NVS)

Thomas MacArthur (R-NJ), a U.S. Representative, has disclosed 27 trades in Novartis AG ADR (NVS) since 2015, 16 purchases and 11 sales, worth an estimated $522K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Thomas MacArthur sold $1,001 - $15,000 of Novartis AG ADR (NYSE: NVS) on October 14, 2016. Since that trade, NVS is up +235.82% against the S&P 500 up +298.78%, an outperformance of -62.96%.

Across these filings, Thomas MacArthur has been a net buyer of NVS (a buy-to-sell ratio of 1.45). The most recent disclosed NVS transaction shown was dated May 11, 2018. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

NVS trades
27
Disclosed Vol
$522K
Buys
16
59%
Sells
11
41%
Buy / Sell
1.45
ratio
First → Last
2015–2018

Thomas MacArthur's NVS trades vs the price

NVS is up +235.82% since Thomas MacArthur sold on October 14, 2016, versus +298.78% for the S&P 500.

Performance since this trade

Price change since trade
+235.82%
S&P 500 change since trade
+298.78%
Outperformance vs S&P 500
-62.96%

All Thomas MacArthur NVS trades

TradedTypeSizeReturnEst. profit
May 11, 2018SELL$51.79+206.70%
April 25, 2018BUY$51.03+211.23%+$9K
July 28, 2017SELL$54.60+190.91%
July 28, 2017SELL$54.60+190.91%
April 21, 2017BUY$47.29+235.90%+$9K
November 3, 2016SELL$43.46+265.45%
October 14, 2016SELL$47.30+235.82%
September 13, 2016SELL$49.18+222.96%
June 13, 2016BUY$48.07+230.44%+$8K
June 13, 2016BUY$48.07+230.44%+$8K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Thomas MacArthur & NVS trading FAQ

Is it legal for Thomas MacArthur to trade Novartis AG ADR (NVS) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Novartis AG ADR (NVS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Thomas MacArthur sell NVS?

Thomas MacArthur disclosed a sale of $1,001 - $15,000 of Novartis AG ADR (NVS) on October 14, 2016, according to public STOCK Act filings.

How has NVS performed since Thomas MacArthur's trade?

Since Thomas MacArthur sold NVS on October 14, 2016, the stock is up +235.82%, versus +298.78% for the S&P 500 over the same period, an outperformance of -62.96%.

How many times has Thomas MacArthur traded NVS?

Thomas MacArthur has disclosed 27 NVS trades since 2015 (16 purchases and 11 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional NVS trades?

Quantellect tracks every disclosed congressional trade in Novartis AG ADR (NVS) on the Novartis AG ADR congressional trading page, which aggregates filings across all members of Congress.

Thomas MacArthur's NVS tradesAll congressional filings for Novartis AG ADRThomas MacArthur's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.